U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Crovalimab
H9KH1GP3UU
US Approved Rx (2024)
First approved in 2024
General
Names
14
Classification
1
Identifiers
7
Subunits
4
Related Substances
1
Crovalimab
H9KH1GP3UU
US Approved Rx (2024)
First approved in 2024
General
Approval Year
2024
711
Names
14
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
Crovalimab
Official Name
English
RG-6107
Preferred Name
English
RG6107
Code
English
Crovalimab [WHO-DD]
Common Name
English
RO7112689
Code
English
Showing 1 to 5 of 14 entries
Previous
1
2
3
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of paroxysmal nocturnal hemoglobinuria (PNH)
FDA ORPHAN DRUG
590717
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
H9KH1GP3UU
PRIMARY
USAN
GH-174
PRIMARY
DAILYMED
H9KH1GP3UU
PRIMARY
CAS
1917321-26-6
PRIMARY
NCI_THESAURUS
C169867
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
H9KH1GP3UU
Crovalimab
